Subscribe
Conference Correspondent

Preparing Your Patients for Side Effects

Hematologic Cancers, Conference Correspondent, ASH
Conference Correspondent 
Tiffany Richards stresses the importance of educating patients about side effects and what to do when these side effects begin to present.

Related Items

Single-Drug Targeted Therapy May Improve Proportion of Patients With Hard-to-Treat Leukemias Proceeding to Transplant
By Wayne Kuznar
TON - February 2024 Vol 17, No 1
Leukemia, ASH
Isatuximab plus RVd Achieves Highest Rates of No MRD in Multiple Myeloma
By William King
TON - April 2022 Vol 15, No 2
ASH, Hematologic Malignancies
Addition of Ivosidenib to Azacitidine Improves Outcomes for Patients with AML and IDH1 Mutation
By Patricia Stewart
TON - April 2022 Vol 15, No 2
ASH
POLARIX Trial Results Support Use of Polatuzumab Vedotin plus R-CHP as Frontline Treatment for DLBCL
By Patricia Stewart
TON - April 2022 Vol 15, No 2
ASH
Circulating Tumor DNA Profiling May Allow for Better Detection and Treatment of CNS Lymphoma
By Patricia Stewart
TON - April 2022 Vol 15, No 2
ASH
CAR T-Cell Therapies May Improve Outcomes in Relapsed/Refractory Large B-Cell Lymphoma
TON - February 2022 Vol 15, No 1
ASH, Lymphoma
Studies Shed New Light on Antibody Responses to COVID-19 Vaccines in Patients with Hematologic Diseases
TON - February 2022 Vol 15, No 1
ASH
Mosunetuzumab Demonstrates Efficacy in Patients with Relapsed/Refractory Follicular Lymphoma
TON - February 2022 Vol 15, No 1
ASH
Axicabtagene Ciloleucel Induces Durable Responses in Advanced Follicular Lymphoma and Marginal-Zone Lymphoma
By William King
TON - August 2020, Vol 13, No 4
Hematologic Cancers
CAR T-Cell Therapy Shows Highly Durable Remissions in CLL and B-Cell Lymphoma
By Charlie Dawson
TON - August 2020, Vol 13, No 4
Hematologic Cancers

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Sign Up for The Oncology Nurse®‑APN/PA

Subscribe to receive the free, monthly TON print publication and TON weekly e‑newsletter.

Subscribe
© Amplity Health. All Rights Reserved. Privacy Policy.